Appropriate Use Criteria for 18F-FDG PET/CT in Restaging and Treatment Response Assessment of Malignant Disease.
Publication
, Journal Article
Jadvar, H; Colletti, PM; Delgado-Bolton, R; Esposito, G; Krause, BJ; Iagaru, AH; Nadel, H; Quinn, DI; Rohren, E; Subramaniam, RM; Zukotynski, K ...
Published in: J Nucl Med
December 2017
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Nucl Med
DOI
EISSN
1535-5667
Publication Date
December 2017
Volume
58
Issue
12
Start / End Page
2026 / 2037
Location
United States
Related Subject Headings
- Treatment Outcome
- Positron Emission Tomography Computed Tomography
- Nuclear Medicine & Medical Imaging
- Neoplasms
- Neoplasm Staging
- Humans
- Fluorodeoxyglucose F18
- 3202 Clinical sciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Jadvar, H., Colletti, P. M., Delgado-Bolton, R., Esposito, G., Krause, B. J., Iagaru, A. H., … Griffeth, L. (2017). Appropriate Use Criteria for 18F-FDG PET/CT in Restaging and Treatment Response Assessment of Malignant Disease. J Nucl Med, 58(12), 2026–2037. https://doi.org/10.2967/jnumed.117.197988
Jadvar, Hossein, Patrick M. Colletti, Roberto Delgado-Bolton, Giuseppe Esposito, Bernd J. Krause, Andrei H. Iagaru, Helen Nadel, et al. “Appropriate Use Criteria for 18F-FDG PET/CT in Restaging and Treatment Response Assessment of Malignant Disease.” J Nucl Med 58, no. 12 (December 2017): 2026–37. https://doi.org/10.2967/jnumed.117.197988.
Jadvar H, Colletti PM, Delgado-Bolton R, Esposito G, Krause BJ, Iagaru AH, et al. Appropriate Use Criteria for 18F-FDG PET/CT in Restaging and Treatment Response Assessment of Malignant Disease. J Nucl Med. 2017 Dec;58(12):2026–37.
Jadvar, Hossein, et al. “Appropriate Use Criteria for 18F-FDG PET/CT in Restaging and Treatment Response Assessment of Malignant Disease.” J Nucl Med, vol. 58, no. 12, Dec. 2017, pp. 2026–37. Pubmed, doi:10.2967/jnumed.117.197988.
Jadvar H, Colletti PM, Delgado-Bolton R, Esposito G, Krause BJ, Iagaru AH, Nadel H, Quinn DI, Rohren E, Subramaniam RM, Zukotynski K, Kauffman J, Ahuja S, Griffeth L. Appropriate Use Criteria for 18F-FDG PET/CT in Restaging and Treatment Response Assessment of Malignant Disease. J Nucl Med. 2017 Dec;58(12):2026–2037.
Published In
J Nucl Med
DOI
EISSN
1535-5667
Publication Date
December 2017
Volume
58
Issue
12
Start / End Page
2026 / 2037
Location
United States
Related Subject Headings
- Treatment Outcome
- Positron Emission Tomography Computed Tomography
- Nuclear Medicine & Medical Imaging
- Neoplasms
- Neoplasm Staging
- Humans
- Fluorodeoxyglucose F18
- 3202 Clinical sciences
- 1103 Clinical Sciences